AzTrials
AzTrials

Pregnancy RelatedNCT04238585

BabyQ's: Randomized Controlled Trial of Health Messaging in Pregnancy and Infancy

A study testing Mobile messaging in people with Pregnancy Related and Infant Development, run by Columbia University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled intervention evaluates the effect of a mobile health behavioral intervention to test messages to reduce sugar-sweetened beverage intake during pregnancy and infancy. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Pregnancy Related, Infant Development
What is being tested?
Mobile messaging
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
291 participants
Where
1 siteUnited States
Study dates
27 Jan 2020to 17 Feb 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Pregnant women age 18 years or older or; legal caretakers of infants under 24 months enrolled in WIC
  • Can respond to questions in English or Spanish
  • Report use of a mobile device using iOS or Android
  • Give permission to enroll in messaging system

Who cannot join

  • Pregnant women with chronic medical conditions that may impact their nutrition behaviors
  • Families whose eligible child has chronic conditions that interest with growth or feeding

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Columbia University

    New York, New York, 10032

Other trials in United States

About this study

Official title: Intervening to Promote Healthy Weight From Gestation to Age 2, Particularly Among Disproportionately Burdened Populations

This randomized controlled intervention evaluates the effect of a mobile health behavioral intervention to test messages to reduce sugar-sweetened beverage intake during pregnancy and infancy.

The study team will perform a prospective, longitudinal, interventional, randomized control trial by recruiting 300 WIC families during the first 1,000 days of life (pregnancy through infant age 2 months) at consecutive Women, Infants, and Children (WIC) visits to test two interventions compared to a control group. The study team will implement a mobile-based messaging intervention allocate participants to one of 3 arms for a 1 month period: 1) negative message frames, 2) positive message frames, and 3) attention control.

Read the detailed description

Childhood obesity prevalence soared over the past four decades with a 10-fold increase globally from 1975-2015 and Healthy People 2020 has declared obesity a national health priority. Socioeconomic and racial/ethnic disparities in obesity exist and may be widening. These disparities are apparent by age 2 years with recent national data showing that Hispanic children continue to have highest obesity prevalence (15.6%) and on-Hispanic black children have 2-fold higher obesity prevalence (10.4%) compared to non-Hispanic white (5.2%) counterparts. The first 1,000 days describes the period from pregnancy through child age 2 years, and is increasingly recognized as a critical period for development of childhood obesity and its adverse consequences. Several risk factors are consistently associated with later childhood obesity during the first 1,000 days and are more prevalent among low socioeconomic groups and racial/ethnic minorities. These modifiable risk factors mediate the development of racial/ethnic disparities in later childhood obesity.

Sugar-sweetened beverage (SSB) consumption during the first 1,000 days is a risk factor for childhood overweight/obesity, and has been linked to dental caries, lower child cognition, and the adverse child health consequences. Recent evidence shows that maternal SSB consumption during pregnancy and infant SSB consumption in the first year of life are associated with childhood obesity later in life. Thus, interventions to curb SSB consumption and promote healthy beverage intake in urban, low-income Hispanic/Latino families must start early in life, yet few SSB-specific interventions have ventured to do so.

Being tested
Mobile messaging
Keywords
Sugar-sweetened beverages, Early life nutrition, First 1000 Days

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mobile messagingBehavioural

    Mobile health messages

Study groups in NCT04238585
Study groupRoleWhat they receive
Negative message framesActive comparatorParticipants will receive messages framed in a negative manner to avoid sugar-sweetened beverages
Receives: Behavioral: Mobile messaging
Sugar content information messagesActive comparatorParticipants will receive messages framed in a positive manner to promote healthy beverage consumption
Receives: Behavioral: Mobile messaging
Attention Control-Infant SafetyPlacebo comparatorParticipants will receive messages with infant safety education materials-attention control group
Receives: Behavioral: Mobile messaging

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in sugar-sweetened beverage (SSB) intake in kcals among adult participants

    Determine change from baseline to follow-up in habitual daily caloric intake of SSBs using parent self report of beverage intake

    Measured: 1 month

Secondary outcomes (1)
  1. Change in sugar-sweetened beverage (SSB) intake in infants

    Determine change from baseline to follow-up in parent-reported infant SSB intake using logistic regression to examine a categorical outcome (any infant SSB consumption v. none)

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jan 2020
  2. Study start27 Jan 2020
  3. Primary completion17 Feb 2021
  4. Study completion17 Feb 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Single group
Model description
Families who present for a routine WIC visit will be referred for study staff recruitment if they meet either of the following criteria: 1) pregnant woman or 2) parent of child \<24 months enrolled in WIC.
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
291 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04238585
Sponsor's protocol ID
AAAS0859
Status last verified
Nov 2021
First submitted
16 Jan 2020
Last updated
16 Nov 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Mobile messaging in people with Pregnancy Related and Infant Development, run by Columbia University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in sugar-sweetened beverage (SSB) intake in kcals among adult participants (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in